DC
JAZZ icon

Davenport & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

Davenport & Co’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$769K Buy
+3,190
New +$699K ﹤0.01% 858

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Davenport & Co's JAZZ Position: Q2 2026 in Review

Davenport & Co opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 3,190 shares worth $769K. The stake represents ﹤0.01% of the portfolio and ranks #858 among its holdings.

106 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Davenport & Co held 3,190 shares of Jazz Pharmaceuticals worth $769K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Davenport & Co position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Davenport & Co's portfolio in Q2 2026, its #858 holding.
  • 106 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.